We are talking about the stages required for developing drugs from the original concept, We have generated enough support to get ready for Investigational New Drug (IND) filing, so that you can get a drug ready for use in humans.

All work needs to performed to Good Laboratory Practise (GLP) standards.

In the experimental (non-clinical) research arena, the phrase good laboratory practice or GLP specifically refers to a quality system of management controls for research laboratories and organizations to try to ensure the uniformity, consistency, reliability, reproducibility, quality, and integrity of chemical (including pharmaceuticals) non-clinical safety tests; from physio-chemical properties through acute to chronic toxicity tests.

Many universities do not work to these standards and so again one has to enlist the services of a Contract Research Organisation to do these studies.

Pharma will also the services of CRO, as this gives a measure of independence and there are significant costs here.

GLP applies to non-clinical studies conducted for the assessment of the safety or efficacy of chemicals (including pharmaceuticals) to man, animals and the environment. An internationally recognized definition of GLP can be found on the website for the Medicines and Healthcare products Regulatory Agency-UK (CLICK here)

Good Laboratory Practice embodies a set of principles that provides a framework within which laboratory studies are planned, performed, monitored, recorded, reported and archived. These studies are undertaken to generate data by which the hazards and risks to users, consumers and third parties, including the environment, can be assessed for pharmaceuticals (only preclinical studies). GLP helps assure regulatory authorities that the data submitted are a true reflection of the results obtained during the study and can therefore be relied upon when making risk/safety assessments.